Oramed to Present at BIO International Convention
NEW YORK, June 3, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Dr. Mark Hasleton, Vice President Business Development of Oramed, will deliver a corporate presentation, including an update regarding the completed enrollment of the Phase IIb HbA1c […]
